U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07400926) titled 'Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg' on Feb. 03.
Brief Summary: Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Study Start Date: Dec. 17, 2025
Study Type: OBSERVATIONAL
Condition:
Open-angle Glaucoma, Ocular Hypertension
Intervention:
COMBINATION_PRODUCT: Travoprost
Travoprost intracameral implant, 75mcg administered using the sterile, single-dose updated inserter (Model G2-TRIO)
Recruitment Status: RECRUITING
Sponsor: Glaukos Corporation
Published by HT Digital Cont...